We hold pharmaceutical companies responsible for drug-induced illness.

Zostavax

We represent people sickened by the Zostavax Vaccine.

The Zostavax® vaccine may cause several major side effects, including shingles,
blindness, and death. Although the vaccine is approved for older adults, it is only about 50 percent effective, according to the U.S. Food and Drug Administration (FDA).

The FDA approved Zostavax in 2006 as a vaccine intended to prevent shingles in adults 50 years of age and older. However, the CDC recommends only administering the vaccine to those healthy adults who are over the age of 59. Until 2017, Zostavax was the only vaccine on the market licensed to prevent the shingles virus or herpes zoster. The pharmaceutical manufacturer Merck & Co. makes the Zostavax vaccine. It is administered as a one-time injectable dose at a doctor’s office or pharmacy, and the effectiveness only lasts for five years.

Symptoms of the shingles virus manifest along one side of the body as a painful rash. The skin may also blister. Shingles is caused by the chickenpox virus or varicella zoster. Chickenpox can remain dormant in your nerve tissues for years and may reactivate when your immune system weakens with age or illness.

Zostavax, a live vaccine, contains a live but weakened strain of the chickenpox virus. This small amount of live virus activates the immune system. By fighting this strain of chickenpox or varicella zoster virus, the patient can generally build up immunity and prevent shingles.

Several side effects may occur after taking Zostavax, some are minimal while others are fatal. Most people receiving Zostavax experience little to no negative reactions. However, this is not true for people who have a suppressed immune system. The vaccine can be particularly dangerous for patients with autoimmune diseases such as AIDS and cancers like leukemia and lymphoma.

People with severe allergies to gelatin and antibiotic neomycin and those who are pregnant should not receive the Zostavax vaccine, the CDC warns.

The package insert on file with the FDA lists the following possible Zostavax side effects:

  • Death
  • Fever
  • Nausea
  • Shingles
  • Headache
  • Anaphylaxis
  • Chickenpox
  • Hives & Rash
  • Joint & Muscle Pain
  • Congestive Heart Failure
  • Nerve Damage & Paralysis
  • Serious Cardiovascular Events
  • Necrotizing Retinitis & Blindness
  • Meningoencephalitis & Brain Injury

People across the country have filed Zostavax lawsuits. Plaintiffs involved in these cases allege that they suffered serve reactions after receiving the Zostavax vaccine. They also argue that pharmaceutical maker Merck & Co. knew about the side effects but failed to warn the public. The plaintiffs claim that had they been warned of the potential risks, they may not have chosen to be vaccinated. One complaint notes that between 2006 and 2015, over 1,000 reports were made to the Vaccine Adverse Events Reporting System (VAERS) for shingles vaccines. The complications reported to VAERS even include death.

How Waters Kraus Paul & Siegel can help people sickened by Zostavax

For over 20 years, Waters Kraus Paul & Siegel has represented people affected by unsafe products, such as dangerous pharmaceuticals and faulty medical devices. We are the only plaintiffs’ law firm to obtain a verdict in a PPA (phenylpropanolamine)/stroke case against Bayer, the pharmaceutical maker. Our drug injury lawyers stood up for families whose children suffered blistering skin reactions after taking prescription drugs. With a national presence and a wealth of experience, our firm has the resources to champion your case in any court in the country. To have one of our lawyers review your potential Zostavax case, email us or call 800.226.9880.

Side Effects Linked to Zostavax:

  • Death
  • Fever
  • Nausea
  • Shingles
  • Headache
  • Anaphylaxis
  • Chickenpox
  • Hives & Rash
  • Joint & Muscle Pain
  • Congestive Heart Failure
  • Nerve Damage & Paralysis
  • Serious Cardiovascular Events
  • Necrotizing Retinitis & Blindness
  • Meningoencephalitis & Brain Injury

For Mesothelioma Survivors: New Treatments Bring Hope

February 11, 2026 The most encouraging news for patients focused on surviving mesothelioma is that treatment is evolving rapidly. Once limited to surgery or chemotherapy alone, doctors now combine therapies and explore new approaches to improve survival and quality of life. New treatments…

Chemical Hazards in the Workplace: Semiconductor Manufacturing

February 3, 2026 Companies have been ramping up production of semiconductors in the U.S., following the 2022 passage of the CHIPS and Science Act, which provides billions in new funding to boost domestic research and manufacturing of semiconductors. With electronic and tech companies…
A technician in a cleanroom environment with graphics highlighting common semiconductor chemicals like PFAS and solvents.

Peter Kraus Inducted into D Magazine’s Hall of Fame

January 22, 2026 Waters Kraus Paul & Siegel is proud to congratulate firm co-founder Peter Kraus on his induction into the D Magazine Hall of Fame. Peter’s commitment to representing individuals harmed by negligent corporate practices, including exposure to toxic chemicals and asbestos, has made him a widely respected leader in plaintiff-side litigation. Since co-founding the firm, he has helped build Waters Kraus Paul & Siegel into one of the nation’s premier trial firms, earning record verdicts and settlements on behalf of clients seeking justice against powerful corporate interests. This latest recognition reflects not only Peter’s sustained professional excellence but also his dedication…
Portrait of attorney Peter Kraus, co-founder of Waters Kraus Paul & Siegel, celebrating his D Magazine Hall of Fame induction.

Top 3 Reasons to Avoid Zostavax

December 2, 2021 Shingles is a painful rash with blisters that adults over age 50 can prevent with a simple vaccine. But, they may need to make an informed decision on which vaccine will work the best for them. With nearly one in...

Increase in Shingles Vaccination Despite Zostavax Lawsuits

March 17, 2021 Hopes were high when the FDA approved the use of Zostavax by Merck in the U.S. The single-dose vaccine licensed for use in healthy Americans age 60 and older seemed to ease the worry of those who would otherwise be...

Our Results

$880 million award

Historic settlement for over 1,300 survivors of clergy and adult abuse within the Roman Catholic Archdiocese of Los Angeles, marking a pivotal moment for justice.

READ THE DETAILS

$725.5 million award

A Philadelphia jury awarded a record verdict against ExxonMobil for failing to warn about cancer risks due to benzene in its petroleum products.

READ THE DETAILS

$25 million award

Private equity firm and co-defendants agree to pay $25M in Medicaid fraud case alleging mental health services provided by unqualified providers.

READ THE DETAILS